-
Efficacy of weekly trastuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes = [Učinkovitost trastuzumaba in paclitaxela pri zdravljenju bolnic z metastatskim rakom dojke in izraženim HER-2/neu onkogenom]Janku, Filip ...Purpose. Trastuzumab is known as an active agent in HER2/neu overexpressing metastatic breast cancer. In the prospective study we investigated efficacy, safety and toxicity of trastuzumab and ... paclitaxel in metastatic breast cancer progressing on previous therapy. Patients and methods. We accrued 17 patients with histologically confirmed breast cancer, Karnofsky performance status at least 60 %, median age 50 (36-66), pretreated with at least two regimens. HER-2/neu expression was tested by HercepTest (r) (DAKO) in all 17 patients. Fifteen specimens were 3+ positive and 2 specimens 2+ positive. All patients except one were pretreated with taxanes. Taxane free interval (TFI) was defined as a time from last taxane administration until the beginning of the study for every enrolled patient. TFI longer than 1 year was found in 7 patients. TFI shorter than 1 year was observed in 9 patients. Trastuzumab was given 4 mg/kg i.v. as a loading dose followed by 2 mg/kg i.v. weekly. Paclitaxel was given 80 mg/m2 i.v. weekly until disease progression or unacceptable toxicity. We assessed the response rate (RR), the time to progression (TTP), the survival (OS) and toxicity. (Abstract truncated at 2000characters)Vir: Radiology and oncology. - ISSN 1318-2099 (Letn. 36, št. 2, 2002, str. 121-129)Vrsta gradiva - članek, sestavni delLeto - 2002Jezik - angleškiCOBISS.SI-ID - 15184601
Avtor
Janku, Filip |
Petruzelka, Lubos |
Pribylová, Olga |
Vedralova, Jana |
Honova, Hana |
Pecen, Ladislav |
Zimovjanova, Martina |
Pozdrova, Gabriela |
Safanda, Martin |
Konopasek, Bohuslav
Teme
Breast neoplasms |
Drug therapy |
Neoplasm metastasis |
Proto-oncogene proteins c-erbb-2 |
Antagonists and inhibitors |
Treatment outcome |
Prospective studies |
Karnofsky performance status |
Survival analysis |
Dojka, novotvorbe |
Novotvorba, metastaza |
Analiza preživetja |
Izid zdravljenja |
Karnofskyva ocena sposobnosti |
Prospektivne študije
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.